مقالههای دارای تعهدات انتشار عمومی - Morten Ruhwaldبیشتر بدانید
جای دیگری دردسترس نیست: ۱۰
Safety and immunogenicity of the chlamydia vaccine candidate CTH522 adjuvanted with CAF01 liposomes or aluminium hydroxide: a first-in-human, randomised, double-blind, placebo …
S Abraham, HB Juel, P Bang, HM Cheeseman, RB Dohn, T Cole, ...
The Lancet infectious diseases 19 (10), 1091-1100, 2019
تعهدات: Innovation Fund Denmark
Bacillus Calmette-Guérin vaccination at birth and in vitro cytokine responses to non-specific stimulation. A randomized clinical trial
TN Nissen, NM Birk, BA Blok, RJW Arts, A Andersen, J Kjærgaard, ...
European Journal of Clinical Microbiology & Infectious Diseases 37, 29-41, 2018
تعهدات: Danish National Research Foundation, European Commission, Research Council …
Use of IFN-γ and IP-10 detection in the diagnosis of latent tuberculosis infection in patients with inflammatory rheumatic diseases
R Villar-Hernández, I Latorre, S Mínguez, J Díaz, E García-García, ...
Journal of Infection 75 (4), 315-325, 2017
تعهدات: Government of Spain
Interaction between C-Tb and PPD given concomitantly in a split-body randomised controlled trial
H Aggerbeck, M Ruhwald, ST Hoff, PN Tingskov, E Hellstrom, ...
The International Journal of Tuberculosis and Lung Disease 23 (1), 38-44, 2019
تعهدات: European Commission
ELISA-based assay for IP-10 detection from filter paper samples
CH Drabe, T Blauenfeldt, M Ruhwald
Cytokine Bioassays: Methods and Protocols, 27-37, 2014
تعهدات: Danish National Advanced Technology Foundation
Safety and Immunogenicity of the H56: IC31 Tuberculosis Vaccine Candidate in Adults Successfully Treated for Drug-Susceptible Pulmonary Tuberculosis: A Phase 1 Randomized Trial
D Tait, A Diacon, ÁH Borges, E van Brakel, D Hokey, KT Rutkowski, ...
The Journal of Infectious Diseases 230 (5), 1262-1270, 2024
تعهدات: Bill & Melinda Gates Foundation
KLRG1-Expressing CD4 T Cells Are Reduced in Tuberculosis Patients Compared to Healthy Mycobacterium tuberculosis–Infected Subjects, but Increase With …
K Tonby, R Mortensen, M Ruhwald, AM Dyrhol-Riise, S Jenum
The Journal of Infectious Diseases 220 (1), 174-176, 2019
تعهدات: Research Council of Norway
Immunogenicity, safety, and efficacy of the vaccine H56: IC31 in reducing the rate of tuberculosis disease recurrence in HIV-negative adults successfully treated for drug …
ÁH Borges, M Russell, D Tait, TJ Scriba, E Nemes, P Skallerup, ...
The Lancet Infectious Diseases, 2025
تعهدات: European Commission
Successful Mycobacterium tuberculosis culture isolation from tongue swabs: Results from both experimentally infected and clinical swabs from pulmonary tuberculosis patients
L Rigouts, M Condé, S Hassane-Harouna, K Bah, M Gumusboga, ...
Diagnostic Microbiology and Infectious Disease 110 (2), 116423, 2024
تعهدات: Bill & Melinda Gates Foundation
Exploring correlates of protection in a tuberculosis vaccine context
LL Holm, T Benfield
Statens Serum Institut, 2018
تعهدات: European Commission
جای دیگری دردسترس است: ۸۲
Antigen availability shapes T cell differentiation and function during tuberculosis
AO Moguche, M Musvosvi, A Penn-Nicholson, CR Plumlee, H Mearns, ...
Cell host & microbe 21 (6), 695-706. e5, 2017
تعهدات: Bill & Melinda Gates Foundation, US National Institutes of Health, European …
Optimization and Interpretation of Serial QuantiFERON Testing to Measure Acquisition of Mycobacterium tuberculosis Infection
E Nemes, V Rozot, H Geldenhuys, N Bilek, S Mabwe, D Abrahams, ...
American journal of respiratory and critical care medicine 196 (5), 638-648, 2017
تعهدات: Bill & Melinda Gates Foundation, US National Institutes of Health
Safety and efficacy of the C-Tb skin test to diagnose Mycobacterium tuberculosis infection, compared with an interferon γ release assay and the tuberculin skin test: a phase 3 …
M Ruhwald, H Aggerbeck, RV Gallardo, ST Hoff, JI Villate, B Borregaard, ...
The Lancet Respiratory Medicine 5 (4), 259-268, 2017
تعهدات: Government of Spain
Diagnostic accuracy of the Cepheid 3-gene host response fingerstick blood test in a prospective, multi-site study: interim results
JS Sutherland, G van der Spuy, A Gindeh, NTT Thuong, AR Namuganga, ...
Clinical infectious diseases 74 (12), 2136-2141, 2022
تعهدات: Bill & Melinda Gates Foundation, US National Institutes of Health, UK …
Detection of isoniazid, fluoroquinolone, ethionamide, amikacin, kanamycin, and capreomycin resistance by the Xpert MTB/XDR assay: a cross-sectional multicentre diagnostic …
A Penn-Nicholson, SB Georghiou, N Ciobanu, M Kazi, M Bhalla, A David, ...
The Lancet Infectious Diseases 22 (2), 242-249, 2022
تعهدات: Federal Ministry of Education and Research, Germany
C-Tb skin test to diagnose Mycobacterium tuberculosis infection in children and HIV-infected adults: A phase 3 trial
H Aggerbeck, M Ruhwald, ST Hoff, B Borregaard, E Hellstrom, ...
PloS one 13 (9), e0204554, 2018
تعهدات: European & Developing Countries Clinical Trials Partnership
Tests for tuberculosis infection: landscape analysis
Y Hamada, DM Cirillo, A Matteelli, A Penn-Nicholson, MX Rangaka, ...
European Respiratory Journal 58 (5), 2021
تعهدات: US Agency for International Development, UK Medical Research Council …
A prospective multicentre diagnostic accuracy study for the Truenat tuberculosis assays
A Penn-Nicholson, SN Gomathi, C Ugarte-Gil, A Meaza, E Lavu, P Patel, ...
European Respiratory Journal 58 (5), 2021
تعهدات: Bill & Melinda Gates Foundation
A phase 1b randomized study of the safety and immunological responses to vaccination with H4: IC31, H56: IC31, and BCG revaccination in Mycobacterium tuberculosis-uninfected …
LG Bekker, O Dintwe, A Fiore-Gartland, K Middelkoop, J Hutter, ...
EClinicalMedicine 21, 2020
تعهدات: Bill & Melinda Gates Foundation, US National Institutes of Health …
Reimagining the status quo: How close are we to rapid sputum-free tuberculosis diagnostics for all?
RR Nathavitharana, AL Garcia-Basteiro, M Ruhwald, F Cobelens, ...
EBioMedicine 78, 2022
تعهدات: US National Institutes of Health, Wellcome Trust
اطلاعات انتشارات و تأمین بودجه بهطورخودکار توسط برنامه رایانهای تعیین میشود.